Mahoney 2023 describes how the Texas Children’s Hospital Center for Vaccine Development has partnered with several LMIC vaccine manufacturers to develop and test coronavirus vaccines.
The International Vaccine Institute (IVI), in collaboration with CEPI, formed a global consortium to develop broadly proactive coronavirus vaccines. IVI and its consortium partners, in alignment with CEPI’s Equitable Access Policy, have committed to equitable vaccine access, with BioNet ensuring affordability and plans for future technology transfer to LMIC producers.